Sagimet Biosciences Files 8-K on Operations and Financials
Ticker: SGMT · Form: 8-K · Filed: May 15, 2024 · CIK: 1400118
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Sagimet Biosciences filed an 8-K updating its financials and operations - check the full report for details.
AI Summary
Sagimet Biosciences Inc. filed an 8-K on May 15, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational updates beyond the general categories of information being reported.
Why It Matters
This 8-K filing indicates Sagimet Biosciences is providing updates on its financial condition and operational results to the SEC. Investors should review the full filing for specific details.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any new or significant negative developments.
Key Players & Entities
- Sagimet Biosciences Inc. (company) — Registrant
- May 15, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 155 Bovet Road, Suite 303, San Mateo, California 94402 (address) — Principal Executive Offices
- (650) 561-8600 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are being reported by Sagimet Biosciences Inc. in this 8-K?
The filing indicates that the 8-K is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but it does not provide specific figures or details within the provided text.
When was this 8-K report filed with the SEC?
The report was filed on May 15, 2024.
What is the principal business address of Sagimet Biosciences Inc.?
The principal executive offices are located at 155 Bovet Road, Suite 303, San Mateo, California 94402.
What is the Commission File Number for Sagimet Biosciences Inc.?
The Commission File Number is 001-41742.
What is the IRS Employer Identification Number for Sagimet Biosciences Inc.?
The I.R.S. Employer Identification No. is 20-5991472.
Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-05-15 08:05:18
Key Financial Figures
- $0.0001 — ich registered Series A Common Stock, $0.0001 par value per share SGMT The Nasdaq G
Filing Documents
- tm2414482d1_8k.htm (8-K) — 28KB
- tm2414482d1_ex99-1.htm (EX-99.1) — 50KB
- tm2414482d1_ex99-1img001.gif (GRAPHIC) — 3KB
- 0001104659-24-061609.txt ( ) — 262KB
- sgmt-20240515.xsd (EX-101.SCH) — 3KB
- sgmt-20240515_lab.xml (EX-101.LAB) — 33KB
- sgmt-20240515_pre.xml (EX-101.PRE) — 22KB
- tm2414482d1_8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Document 99.1 Press Release of Sagimet Biosciences Inc., dated May 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sagimet Biosciences Inc. Date: May 15, 2024 By: /s/ David Happel David Happel Chief Executive Officer